Still, news of Amag's biggest deal ever and Chief Executive William Heiden's assertion to hunt for growth through acquisitions failed to move shareholders. The stock was flat in morning trading. Cord Blood Registry (CBR), …
AMAG’s Symmetry™ CompleteView VMS (video management system ... by being the supply partner of choice in all our markets. G4S is quoted …
Arecont Vision
Today, AMAG Pharmaceuticals (NASDAQ:AMAG) stock was downgraded by Needham & Company LLC from …
Stock in Amag Pharmaceuticals (Nasdaq:AMAG) rose more than 8 percent Monday to close at $21.50 after the company announced the appointment of a new chief development and regulatory officer. The Lexington, Mass. …
Cantor analyst William Tanner remains sidelined on shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) amid their nearly 36% crash yesterday. From the analyst’s perspective, his caution is centered not so much …
KeyBank
News headlines about AMAG Pharmaceuticals (NASDAQ:AMAG) have trended somewhat negative recently, …
Pacific Biosciences of California, AMAG Pharmaceuticals and Global Blood Therapeutics were among the biotech stock movers in premarket trading on Tuesday. Now that the Allergan-Pfizer merger is off, Allergan CEO …
AMAG Pharmaceuticals (AMAG) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a …
AMAG) to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million. This proposal represents an approximate 25% premium above the closing price of …
Business Wire
Upon conversion, holders of the notes will receive shares of AMAG's common stock, cash or a combination thereof, at AMAG's election. The interest rate, initial conversion rate and other terms of the notes will be …